Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche/IBM collaboration

This article was originally published in The Gray Sheet

Executive Summary

Firms will collaborate to develop a nanopore-based DNA sequencing system, according to a July 1 announcement. The system will be based on IBM technology that allows "true single molecule sequencing by decoding molecules of DNA as they are threaded through a nanometer-sized pore in a silicon chip"; this approach "holds the promise of significant advantages in cost, throughput, scalability, and speed" compared to currently available systems, the companies claim. Sequencing can provide individual genetic information necessary for effectively diagnosing diseases and providing personalized treatments, Roche notes. The IBM technology, to be marketed by Roche, could allow whole human genome sequencing for as little as $100, the companies claim
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT029123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel